LIQUID BLENZ CORP Recalls Immunity Enhancer Elderberry Products

Source: FDA · New York

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

LIQUID BLENZ CORP is recalling 18,190 bottles of Immunity Enhancer Elderberry due to potential under-processing that may allow growth of Clostridium botulinum.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on June 11, 2026 and geographically references New York. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action, a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.

For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, Food) map to related alerts in the same area of risk - browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.

What Happened

LIQUID BLENZ CORP is voluntarily recalling certain bottles of Immunity Enhancer Elderberry because the products may be under-processed, which could result in the growth of Clostridium botulinum. The recall also notes that the products list health claims.

Which Products Are Affected

The recall covers Immunity Enhancer Elderberry in 16 oz (UPC: 860005735099) and 32 oz (UPC: 195893965434) sizes. A total of 18,190 bottles are affected. The products were distributed in NY and through online sales. Recall number is H-0787-2026. Lot information was not provided.

What You Should Do

Consumers should not use the recalled products. Contact LIQUID BLENZ CORP for information on returns or refunds. The firm initiated the recall and notified customers via multiple methods including email, fax, letter, press release, telephone, and visit.

Why This Matters

The recall involves a potential risk of Clostridium botulinum growth in a food product distributed in New York and online.

Source

FDA recall H-0787-2026 (Class II), initiated 2026-04-06.

Original source: FDA Official Notice ↗

All FDA Recalls →

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
LIQUID BLENZ CORP is recalling 18,190 bottles of Immunity Enhancer Elderberry due to potential under-processing that may allow growth of Clostridium botulinum.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "high" severity. Take precautions and monitor for updates.
What area is affected?
This alert affects New York. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.